Neoadjuvant paclitaxel (P), carboplatin (Ca) and gemcitabine (G) in patients with locally advanced transitional cell carcinoma (TCC) of the bladder: A final report.

被引：0
|
作者：
Smith, D. C.
Mackler, N. J.
Hussain, M. H.
Dunn, R.
Montie, J. E.
Wood, D.
Lee, C. T.
Petrylak, D.
Quinn, D.
Vaishampayan, U.
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Columbia Presbyterian Med Ctr, New York, NY USA
[3] Univ So Calif, Los Angeles, CA USA
[4] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：226S / 226S
页数：1
相关论文
共 50 条
  • [31] Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma -: Carboplatin and gemcitabine followed by paclitaxel
    De Castro, J
    Feliu, J
    Casado, E
    Ordoñez, A
    Barón, MG
    CANCER, 2002, 94 (10) : 2797 - 2798
  • [32] Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma - Carboplatin and gemcitabine followed by paclitaxel
    Edelman, MJ
    Gandara, DR
    Lau, DHM
    Lara, P
    Lauder, IJ
    Tracy, D
    CANCER, 2001, 92 (01) : 146 - 152
  • [33] Plasmacytoid transitional cell carcinoma (P-TCC) of urinary bladder: A clinicopathologic study in 7 patients
    Lee, HI
    Jung, SJ
    Lee, S
    Ro, JY
    MODERN PATHOLOGY, 2005, 18 : 151A - 151A
  • [34] Plasmacytoid transitional cell carcinoma (P-TCC) of urinary bladder: A clinicopathologic study in 7 patients
    Lee, HI
    Jung, SJ
    Lee, S
    Ro, JY
    LABORATORY INVESTIGATION, 2005, 85 : 151A - 151A
  • [35] A phase II trial of neoadjuvant ABI-007, carboplatin, and gemcitabine (ACG) in patients with locally advanced carcinoma of the bladde
    Smith, D. C.
    Grivas, P.
    Daignault, S.
    Hafez, K.
    Wood, D. P.
    Lee, C. T.
    Montie, J. E.
    Weizer, A. Z.
    Montgomery, J.
    Hussain, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [36] Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial
    De Santis, M.
    Bachner, M.
    Cerveny, M.
    Kametriser, G.
    Steininger, T.
    Koenigsberg, R.
    Schratter-Sehn, A.
    Sedlmayer, F.
    Dittrich, C.
    ANNALS OF ONCOLOGY, 2014, 25 (09) : 1789 - 1794
  • [37] Gemcitabine (G) and vinorelbine (V) in pretreated or elderly transitional cell carcinoma (TCC) patients (PTS): A phase II study
    Ferrau, F
    Bordonaro, R
    Aiello, R
    Cordio, S
    Failla, M
    Giuffrida, D
    Lavenia, G
    Pappalardo, A
    Priolo, D
    Failla, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S352 - S352
  • [38] NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE BLADDER - DO LOCAL FINDINGS SUGGEST A POTENTIAL FOR SALVAGE OF THE BLADDER
    ZINCKE, H
    SEN, SE
    HAHN, RG
    KEATING, JP
    MAYO CLINIC PROCEEDINGS, 1988, 63 (01) : 16 - 22
  • [39] Results at 5 years of intra vesical gemcitabine (G) single agent as adjuvant chemotheray in superficial transitional cell carcinoma (TCC) of the bladder
    Smaili, F.
    Bounedjar, A.
    Ferhat, R.
    Bouzid, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] Liposome-paclitaxel and carboplatin combination chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma
    Zeng, J.
    Cui, X.
    Cheng, L.
    Chen, Y.
    Du, X.
    Sheng, L.
    CANCER RADIOTHERAPIE, 2021, 25 (05): : 441 - 446
12345